Current Edition

ocular

Salvat heads to regulators with phase 3 data on ocular steroid

Salvat is gearing up to launch an ocular corticosteroid treatment for inflammation and pain in cataract surgery patients after finishing phase 3 trials and starting …

Continue Reading →
CAR T

Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment

Existing CAR-T therapies have been saved for blood cancer patients who’ve tried multiple treatments—until now. With a first-in-class nod, the FDA has cleared Yescarta, a …

Continue Reading →
cancer

Considerations for Clinical Trial Design Involving Radiotherapy

Radiation therapy has been used for many years as an effective form of treatment against many cancer types, yet it remains less well researched and …

Continue Reading →
cancer

Doctors Call Off Clinical Trial After Experimental Cancer Treatment Has Tragic Results

 A recent clinical trial attempting to rid three patients of an uncommon type of blood cancer has gone tragically wrong. Rather than fighting the cancer that …

Continue Reading →
atrophy

Scotland Leads the Way in Approval of First Licensed Treatment for Life-Threatening Genetic Disease Affecting Children

Routine access to Spinraza® (nusinersen) for type 1 spinal muscular atrophy granted, with discussions continuing to secure access for other forms of the disease The …

Continue Reading →
clinical

Viracta Initiates Treatment of First Patient in EBV+ Lymphoma Clinical Trial with Tractinostat

Viracta Therapeutics, a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other serious diseases, has initiated treatment of the first patient …

Continue Reading →
Europe

The University of Texas Md Anderson Cancer Center and Nanobiotix have an agreement to run Immunotherapeutic Pre-Clinical Research in Lung Cancer combining Nbtxr3 and Nivolumab

 NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that it will cooperate …

Continue Reading →
clinical

Patients Regain Sight With Stem Cell Treatment In U.K. Clinical Trial

Nearly three years ago, 86-year-old Douglas Waters developed severe vision problems. He was diagnosed with severe wet age-related macular degeneration(AMD), a chronic eye disease that causes blurred …

Continue Reading →
multicentre study

Emotional Brain’s FSIAD Products Lybrido and Lybridos show High Efficacy and Safety in Phase 2B Trials

Emotional Brain is pleased to announce the publication of positive phase 2B results in the authoritative Journal of Sexual Medicine. Lybrido and Lybridos were successfully tested …

Continue Reading →
biomarker

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker panel in the blood. …

Continue Reading →